Amalgamated Bank’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.73M Sell
52,339
-226
-0.4% -$7.47K 0.01% 839
2025
Q1
$2.11M Sell
52,565
-1,057
-2% -$42.5K 0.02% 750
2024
Q4
$2.52M Hold
53,622
0.02% 714
2024
Q3
$2.83M Sell
53,622
-1,775
-3% -$93.7K 0.02% 665
2024
Q2
$3M Buy
55,397
+4,099
+8% +$222K 0.03% 680
2024
Q1
$3.6M Buy
51,298
+10,469
+26% +$734K 0.03% 633
2023
Q4
$3.41M Sell
40,829
-1,024
-2% -$85.5K 0.03% 684
2023
Q3
$1.23M Sell
41,853
-509
-1% -$15K 0.01% 1040
2023
Q2
$1.38M Buy
42,362
+864
+2% +$28.2K 0.01% 1011
2023
Q1
$1.46M Sell
41,498
-2,446
-6% -$86.1K 0.01% 977
2022
Q4
$2.01M Buy
43,944
+83
+0.2% +$3.8K 0.02% 896
2022
Q3
$2.13M Buy
43,861
+3,453
+9% +$167K 0.02% 817
2022
Q2
$1.59M Buy
40,408
+489
+1% +$19.2K 0.01% 951
2022
Q1
$1.47M Sell
39,919
-2,334
-6% -$85.9K 0.01% 1047
2021
Q4
$1.93M Sell
42,253
-147
-0.3% -$6.7K 0.01% 961
2021
Q3
$1.52M Buy
42,400
+4,628
+12% +$165K 0.01% 1055
2021
Q2
$748K Buy
37,772
+28,175
+294% +$558K 0.01% 1428
2021
Q1
$223K Sell
9,597
-824
-8% -$19.1K 0.01% 1432
2020
Q4
$217K Buy
10,421
+290
+3% +$6.04K 0.01% 1405
2020
Q3
$219K Buy
10,131
+1,151
+13% +$24.9K 0.01% 1280
2020
Q2
$212K Sell
8,980
-1,369
-13% -$32.3K 0.01% 1272
2020
Q1
$122K Sell
10,349
-415
-4% -$4.89K ﹤0.01% 1464
2019
Q4
$114K Buy
10,764
+622
+6% +$6.59K ﹤0.01% 1720
2019
Q3
$115K Sell
10,142
-117
-1% -$1.33K ﹤0.01% 1640
2019
Q2
$115K Buy
+10,259
New +$115K ﹤0.01% 1681